RIGL News and Press, Rigel Pharmaceuticals Inc.

2026-03-10 06:49:37 ET Topline Summary and Update It's been quite a long time since my last review of Rigel Pharmaceuticals ( RIGL ), where I was optimistic about the company's performance in light of the growth of their acquired targeted therapies, as well as their own inte...

2026-03-04 13:30:37 ET More on Rigel Pharmaceuticals Rigel Pharmaceuticals, Inc. (RIGL) Q4 2025 Earnings Call Transcript Rigel Pharmaceuticals, Inc. 2025 Q4 - Results - Earnings Call Presentation Rigel Pharmaceuticals: Continued Financial Performance, Catalysts In 20...

2026-03-03 20:32:12 ET Rigel Pharmaceuticals, Inc. (RIGL) Q4 2025 Earnings Call March 3, 2026 4:30 PM EST... Read the full article on Seeking Alpha For further details see: Rigel Pharmaceuticals, Inc. (RIGL) Q4 2025 Earnings Call Transcript

2026-03-03 18:07:39 ET Image source: The Motley Fool. Tuesday, March 3, 2026 at 4:30 p.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading

2026-03-03 16:05:02 ET More on Rigel Pharmaceuticals Rigel Pharmaceuticals: Continued Financial Performance, Catalysts In 2026 Rigel Pharmaceuticals, Inc. (RIGL) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Rigel Pharma: Formulating A Game Pla...

Rigel Provides Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update PR Newswire Fourth quarter 2025 total revenues of approximately $69.8 million, including record net product sales of $65.4 million and contract revenues of $4.4 million 2025 total re...

2026-03-03 10:04:28 ET Summary After years of volatility and a brutal post-COVID correction, biotech investors have understandably become more selective. In the current climate, investors are looking for companies with funded clinical trials, tangible product pipelines, and balance ...

GitLab Inc. (GTLB) is expected to report $-0.02 for Q4 2026 Ross Stores Inc. (ROST) is expected to report $1.88 for Q4 2026 Advantage Solutions Inc. (ADV) is expected to report $0.07 for Q4 2025 Hyster-Yale Inc. Class A (HY) is expected to report $-1.2 for Q4 2025 Versant Media Gr...

2026-03-02 17:39:28 ET More on Rigel Pharmaceuticals Rigel Pharmaceuticals: Continued Financial Performance, Catalysts In 2026 Rigel Pharmaceuticals, Inc. (RIGL) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Rigel Pharma: Formulating A Game Pla...

Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Full Year 2025 Financial Results and Business Update PR Newswire SOUTH SAN FRANCISCO, Calif. , Feb. 24, 2026 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it will repor...